HOXD13 and amyotrophic lateral sclerosis: Notably, four analytes (sPD-1, sBTLA, sCTLA-4/sCD152, sCD27) demonstrated concurrent elevation in ALS patients versus both HC and Mimics (all p < 0.05, Figure 2A–D).